Voloridge Investment Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-564,044
| Closed | -$23.8M | – | 1403 |
|
|
2024
Q1 | $23.8M | Sell |
564,044
-335,980
| -37% | -$14.2M | 0.09% | 288 |
|
|
2023
Q4 | $38.2M | Buy |
+900,024
| New | +$38.2M | 0.15% | 181 |
|
|
2022
Q1 | – | Sell |
-48,289
| Closed | -$1.57M | – | 1773 |
|
|
2021
Q4 | $1.57M | Sell |
48,289
-43,918
| -48% | -$1.42M | 0.01% | 1143 |
|
|
2021
Q3 | $2.72M | Buy |
+92,207
| New | +$2.72M | 0.02% | 933 |
|